$MREO News Article - Biomarker Data from Phase 1b/2 Investigator-sponsored Trial of Mereo's Alvelestat in Bronchiolitis Obliterans Syndrome (BOS) at the ASH Annual Meeting https://marketwirenews.com/news-releases/biom...95441.html
My Twitter: WhyteStocks